Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Consistency of Three sIPV Batches in Infants
NCT04224519Phase 4Completed
- Sponsor
- Institute of Medical Biology
- Start
- Apr 2018
- Primary completion
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis (3 arms), sponsored by Institute of Medical Biology. Primary endpoints: Seroconversion rate of neutralizing antibody and Local and systemic adverse reactions. Started Apr 2018; status: completed.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT04224519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04224519.